Conclusion
Compared with placebo, oral GKAs alone or combined with metformin seems
to be effective and relatively safe in the treatment of T2DM, which
indicates that oral GKAs can be considered as a monotherapy or a
combination therapy with metformin for T2DM patients. Further clinical
studies are warranted to explore the long-term efficacy and safety of
GKAs.